For years, we’ve treated Painful Diabetic Neuropathy (PDN) largely by trying to turn down the volume on the pain. While relief is critical, the "holy grail" has always been something more: stopping the damage or, dare we dream, reversing it. We have just published the design for a new multicenter randomized controlled trial (RCT) in... Continue Reading →